MSH3 and head and neck squamous cell carcinoma: A similar Brazilian study on patients with HNSCC showed that the MSH3 rs26279 GA or AA genotypes are associated with an approximate nine-fold higher risk of partial response to cisplatin chemoradiation or achieving stable disease than are patients with other genotypes [14].